ZHANG JACK Y. (CEO & CHIEF SCIENTIFIC OFFICER) reported 2 transactions at AMPHASTAR PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/10/2026ACC: 0000889740-26-000003
DirectorOfficer10% Owner· CEO & CHIEF SCIENTIFIC OFFICER
Since Mar 2026
-10.85K
Net shares
Net seller
$209.8K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
10.85K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−7.77K
Price / share
$19.34
Trade value
$150.33K
% of position
0.3%
3/6/2026
2.84M→2.83M
Common Stock
Indirect
Shares
−3.08K
Price / share
$19.34
Trade value
$59.51K
% of position
0.3%
3/6/2026
1.18M→1.18M
Total
Net shares
−10.85K
Net value
-$209.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/6/2026 | F · Tax Withholding | −7.77K | $19.34 | $150.33K | 0.3% | 2.84M | 2.83M |
| Common Stock Indirect | 3/6/2026 | F · Tax Withholding | −3.08K | $19.34 | $59.51K | 0.3% | 1.18M | 1.18M |
| Total | −10.85K | -$209.84K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned6.83M
Total
6.83M indirect6.83M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.83M | Indirect |
| Total | 6.83M | 6.83M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported